Curnutte, John T.
Merck & Co., Inc.,
United States
2025 Rank: 49308
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 1444 out of 166615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 49308 | 53354 |
| Total Cites | 13465 | 14751 |
| H-index | 55 | 57 |
| Hm-index | 22 | 23 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 285 | 308 |
| Number of Single+First Authored Papers | 27 | 27 |
| Total Cites to Single+First Authored Papers | 822 | 891 |
| Number of Single+First+Last Authored Papers | 77 | 77 |
| Total Cites to Single+First+Last Authored Papers | 5078 | 5438 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 9584 | 10077 |
| Ratio of Total Citations to Distinct Citing Papers | 1.40 | 1.46 |
| Self-Citation Percentage |
8.72%
|
|
Curnutte, John T.
Orchard Therapeutics plc,
United Kingdom
2024 Rank: 46076
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 1378 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 46076 | 49978 |
| Total Cites | 12928 | 14162 |
| H-index | 55 | 57 |
| Hm-index | 22 | 23 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 283 | 306 |
| Number of Single+First Authored Papers | 27 | 27 |
| Total Cites to Single+First Authored Papers | 813 | 882 |
| Number of Single+First+Last Authored Papers | 77 | 77 |
| Total Cites to Single+First+Last Authored Papers | 4986 | 5340 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 9189 | 9658 |
| Ratio of Total Citations to Distinct Citing Papers | 1.41 | 1.47 |
| Self-Citation Percentage |
8.71%
|
|
Curnutte, John T.
Orchard Therapeutics plc,
United Kingdom
2023 Rank: 44112
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 1356 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 44112 | 48638 |
| Total Cites | 12425 | 13592 |
| H-index | 54 | 55 |
| Hm-index | 21 | 22 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 275 | 296 |
| Number of Single+First Authored Papers | 26 | 26 |
| Total Cites to Single+First Authored Papers | 789 | 845 |
| Number of Single+First+Last Authored Papers | 75 | 75 |
| Total Cites to Single+First+Last Authored Papers | 4851 | 5182 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 8867 | 9319 |
| Ratio of Total Citations to Distinct Citing Papers | 1.40 | 1.46 |
| Self-Citation Percentage |
8.59%
|
|
Curnutte, John T.
Kleiner Perkins Caulfield and Byers,
United States
2022 Rank: 42577
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 1352 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 42577 | 45551 |
| Total Cites | 10218 | 11212 |
| H-index | 51 | 54 |
| Hm-index | 21 | 22 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 271 | 292 |
| Number of Single+First Authored Papers | 25 | 25 |
| Total Cites to Single+First Authored Papers | 779 | 835 |
| Number of Single+First+Last Authored Papers | 73 | 73 |
| Total Cites to Single+First+Last Authored Papers | 4743 | 5070 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7130 | 7490 |
| Ratio of Total Citations to Distinct Citing Papers | 1.43 | 1.50 |
| Self-Citation Percentage |
8.87%
|
|
Curnutte, John T.
Kleiner Perkins Caulfield and Byers,
United States
2021 Rank: 40394
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 1299 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 40394 | 43013 |
| Total Cites | 9967 | 10953 |
| H-index | 51 | 54 |
| Hm-index | 21 | 22 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 267 | 288 |
| Number of Single+First Authored Papers | 25 | 25 |
| Total Cites to Single+First Authored Papers | 771 | 827 |
| Number of Single+First+Last Authored Papers | 73 | 73 |
| Total Cites to Single+First+Last Authored Papers | 4639 | 4965 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6943 | 7301 |
| Ratio of Total Citations to Distinct Citing Papers | 1.44 | 1.50 |
| Self-Citation Percentage |
9.00%
|
|
Curnutte, John T.
Venture-capital Firm Kleiner Perkins Caulfield and Byers,
United States
2020 Rank: 36628
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 1206 out of 108509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 36628 | 40353 |
| Total Cites | 9623 | 10611 |
| H-index | 50 | 52 |
| Hm-index | 21 | 21 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 263 | 284 |
| Number of Single+First Authored Papers | 25 | 25 |
| Total Cites to Single+First Authored Papers | 755 | 811 |
| Number of Single+First+Last Authored Papers | 73 | 73 |
| Total Cites to Single+First+Last Authored Papers | 4503 | 4833 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6683 | 7038 |
| Ratio of Total Citations to Distinct Citing Papers | 1.44 | 1.51 |
| Self-Citation Percentage |
9.31%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.